TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
TCL Archive Cancer Control Contract Negotiations To Start Soon; Two Weaknesses Occur In Many Proposals March 7, 1975
TCL Archive AIDs Concepts Totaling $13 Million Approved By DCT Board; Will Be Funded By Special Appropriations October 11, 1985